…
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. It operates through three segments: Specialty Property and Casualty, Workers' Compensation Insurance, Segregated Portfolio Cell Reinsurance, and Corporate. The company offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance and captive cell programs for healthcare professional liability insureds. It also provides workers' compensation insurance products, such as guaranteed cost policies, policyholder dividend policies, retrospectively rated policies, and deductible policies, as well as alternative market solutions that include program design, fronting, claims administration, risk management, SPC rental, asset management, and SPC management services for individual companies, agencies, groups, and associations. It markets its products through independent agencies and brokers, as well as an internal business development team. ProAssurance Corporation was founded in 1976 and is headquartered in Birmingham, Alabama.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
ProAssurance Corporation is a U.S. specialty insurance company that underwrites professional liability coverage mainly for healthcare providers and related casualty lines. Long-term growth may be supported by ongoing demand for malpractice protection amid healthcare complexity and regulatory scrutiny, plus the firm's distribution and risk-management capabilities. The company appears positioned to benefit from stable renewal streams and potential consolidation in the medical professional liability market.
Investors should monitor underwriting volatility and adverse reserve development from large malpractice claims, competitive pricing pressure, and sensitivity of investment income to market conditions.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 72.07M | 63.08M | -39.15M | -6.22M | 146.61M |
| Net income | 50.91M | 52.74M | -38.60M | -0.40M | 144.12M |
| Selling general administrative | - | - | - | 5.39M | 5.05M |
| Gross profit | 432.61M | 253.34M | 195.11M | 1101.80M | 1075.44M |
| Reconciled depreciation | 13.69M | 17.75M | 28.10M | 38.06M | 37.25M |
| Ebit | 92.91M | 85.42M | -16.00M | 14.16M | 137.67M |
| Ebitda | 106.60M | 103.17M | 10.02M | 52.22M | 174.92M |
| Depreciation and amortization | 13.69M | 17.75M | 26.02M | 38.06M | 37.25M |
| Non operating income net other | - | - | - | - | 74.41M |
| Operating income | 72.07M | 63.08M | -39.15M | 14.16M | 137.67M |
| Other operating expenses | 1025.96M | 1065.12M | 1169.57M | 1108.02M | 928.83M |
| Interest expense | 20.84M | 22.34M | 23.15M | 20.37M | 19.72M |
| Tax provision | 21.15M | 10.33M | -3.09M | -5.81M | 2.48M |
| Interest income | 17.95M | 0.66M | 16.36M | 15.48M | 29.25M |
| Net interest income | -20.84M | -22.34M | -21.98M | -20.37M | -19.72M |
| Income tax expense | 21.15M | 10.33M | -0.55M | -5.81M | 2.48M |
| Total revenue | 1098.03M | 1128.20M | 1130.42M | 1101.80M | 1075.44M |
| Total operating expenses | 360.54M | 190.26M | 234.26M | 174.16M | -937.76M |
| Cost of revenue | 665.42M | 874.87M | 935.31M | - | - |
| Total other income expense net | -11.79M | -26.79M | -73.49M | -20.37M | 8.94M |
| Net income from continuing ops | 50.91M | 52.74M | -31.04M | -0.40M | 144.12M |
| Net income applicable to common shares | 50.91M | 52.74M | -38.60M | -0.40M | 144.12M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 5447.19M | 5574.27M | 5631.93M | 6438.48M | 6613.54M |
| Intangible assets | 105.94M | 54.20M | 60.31M | 66.83M | 73.34M |
| Other current assets | 32.93M | -4548.20M | 270.93M | -4021.25M | -3497.57M |
| Total liab | 4098.06M | 4372.52M | 4519.94M | 4595.98M | 4763.09M |
| Total stockholder equity | 1349.13M | 1201.75M | 1111.98M | 1842.50M | 1850.45M |
| Other current liab | 3018.40M | 3257.70M | 2934.59M | -28.51M | -22.63M |
| Common stock | 0.64M | 0.64M | 0.64M | 0.63M | 0.63M |
| Capital stock | 0.64M | 0.64M | 0.64M | 0.63M | 0.63M |
| Retained earnings | 1485.64M | 1434.72M | 1381.98M | 1423.29M | 1434.49M |
| Other liab | - | - | - | 3637.62M | 3791.52M |
| Good will | 5.50M | 5.50M | 5.50M | 49.61M | 49.61M |
| Other assets | 4721.41M | 5574.27M | 467.23M | 5692.71M | -3075.51M |
| Cash | 36.49M | 54.88M | 65.90M | 29.96M | 143.60M |
| Cash and equivalents | 36.49M | 54.88M | 65.90M | 29.96M | 143.60M |
| Total current liabilities | 3561.69M | 3828.74M | 2961.89M | 20.01M | 22.63M |
| Current deferred revenue | 403.88M | 418.76M | - | - | - |
| Net debt | 398.57M | 387.38M | 378.41M | 417.03M | 302.23M |
| Short term debt | 125.00M | 125.00M | 3.29M | 20.01M | 290.77M |
| Short long term debt | 125.00M | 125.00M | 125.00M | - | - |
| Short long term debt total | 435.06M | 442.26M | 444.31M | 446.99M | 445.83M |
| Other stockholder equity | -56.10M | -61.22M | -66.15M | 717.19M | 399.05M |
| Property plant equipment | 13.82M | 16.51M | 16.27M | 18.99M | 30.34M |
| Total current assets | 4744.19M | 538.70M | 541.25M | 419.79M | 4901.75M |
| Long term investments | 4338.19M | 4279.98M | 4205.76M | 4210.17M | 4828.32M |
| Net tangible assets | - | - | - | 987.57M | 1298.54M |
| Short term investments | 4092.72M | 4020.44M | 3929.00M | 3717.78M | 4050.71M |
| Net receivables | 582.04M | 656.20M | 235.57M | 693.30M | 707.43M |
| Long term debt | 295.42M | 299.87M | 302.13M | 426.98M | 424.99M |
| Inventory | - | - | -537.25M | - | - |
| Accounts payable | 14.42M | 27.29M | 24.02M | 28.51M | 22.63M |
| Accumulated other comprehensive income | -81.05M | -172.39M | -204.49M | -298.61M | 16.28M |
| Common stock total equity | - | - | - | - | 0.63M |
| Retained earnings total equity | - | - | - | - | 1434.49M |
| Treasury stock | - | - | - | - | -415.96M |
| Non currrent assets other | 106.16M | -452.78M | 3904.67M | -4229.15M | -4787.30M |
| Non current assets total | 703.00M | 223.64M | 4623.44M | 325.98M | 4787.30M |
| Capital lease obligations | 14.64M | 17.39M | 17.18M | 20.01M | 20.84M |
| Long term debt total | 420.42M | 424.87M | 427.13M | 426.98M | 424.99M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | -16.62M | 10.67M | 167.09M | -62.00M | 110.05M |
| Change to liabilities | - | - | - | -11.01M | -105.99M |
| Total cashflows from investing activities | 19.44M | 10.67M | 141.14M | -62.00M | -85.53M |
| Net borrowings | -6.25M | -4.69M | 0.00M | - | -36.11M |
| Total cash from financing activities | -12.20M | -10.97M | -55.31M | -21.80M | -60.62M |
| Change to operating activities | - | - | - | -108.49M | 47.68M |
| Net income | 50.91M | 52.74M | -38.60M | -0.40M | 144.12M |
| Change in cash | -18.39M | -11.02M | 35.94M | -113.64M | -72.18M |
| Begin period cash flow | 54.88M | 65.90M | 29.96M | 143.60M | 215.78M |
| End period cash flow | 36.49M | 54.88M | 65.90M | 29.96M | 143.60M |
| Total cash from operating activities | -25.62M | -10.71M | -49.88M | -29.84M | 73.97M |
| Issuance of capital stock | 0.00M | 0.01M | - | - | - |
| Depreciation | 13.69M | 17.75M | 26.02M | 38.06M | 37.25M |
| Other cashflows from investing activities | 20.27M | -4.88M | 24.69M | -62.00M | 29.84M |
| Dividends paid | 75.02M | 20.91M | 5.38M | 10.77M | 10.76M |
| Change to account receivables | 0.60M | 6.67M | 10.53M | -5.00M | 71.20M |
| Sale purchase of stock | 0.00M | 0.01M | -50.49M | -3.25M | - |
| Other cashflows from financing activities | -5.95M | -6.29M | 0.55M | -7.79M | -13.75M |
| Change to netincome | - | - | - | 57.00M | 0.70M |
| Capital expenditures | 3.60M | 9.02M | 4.79M | 4.35M | 3.84M |
| Cash and cash equivalents changes | - | - | - | - | 155.62M |
| Change in working capital | -126.13M | -95.96M | -81.94M | -124.50M | 12.90M |
| Stock based compensation | 7.85M | 6.20M | 5.25M | 4.83M | 4.39M |
| Other non cash items | 11.27M | -4.28M | 41.17M | 58.79M | -126.01M |
| Free cash flow | -29.22M | -19.73M | -54.67M | -34.19M | 70.13M |
Sector: Financial Services Industry: Insurance - Property & Casualty
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
|---|---|---|---|---|---|---|---|
| CB Chubb Ltd |
2.37 0.64% |
372.70 | 12.11 | 11.83 | 2.13 | 1.75 | 2.45 |
| PGR Progressive Corp |
1.76 0.75% |
235.29 | 11.10 | 13.55 | 1.41 | 3.74 | 1.50 |
| TKOMF Tokio Marine Holdings Inc. |
- -% |
3.53 | 28.94 | 12.24 | 0.01 | 1.87 | 1.61 |
| TKOMY Tokio Marine Holdings Inc |
- -% |
3.72 | 28.73 | 12.25 | 0.01 | 1.87 | 1.61 |
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. It operates through three segments: Specialty Property and Casualty, Workers' Compensation Insurance, Segregated Portfolio Cell Reinsurance, and Corporate. The company offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance and captive cell programs for healthcare professional liability insureds. It also provides workers' compensation insurance products, such as guaranteed cost policies, policyholder dividend policies, retrospectively rated policies, and deductible policies, as well as alternative market solutions that include program design, fronting, claims administration, risk management, SPC rental, asset management, and SPC management services for individual companies, agencies, groups, and associations. It markets its products through independent agencies and brokers, as well as an internal business development team. ProAssurance Corporation was founded in 1976 and is headquartered in Birmingham, Alabama.
100 Brookwood Place, Birmingham, AL, United States, 35209
205 877 4400
972
| Name | Title | Year Born |
|---|---|---|
| Mr. Edward Lewis Rand Jr., CPA | CEO, Pres & Director | 1967 |
| Ms. Dana Shannon Hendricks CPA, CPA | Exec. VP, Treasurer & CFO | 1968 |
| Mr. Jeffrey Patton Lisenby Esq. | Exec. VP, Gen. Counsel, Corp. Sec. & Head of the Corp. Legal Dept | 1969 |
| Mr. Michael Leonard Boguski CPCU | Pres of Specialty Property & Casualty Segment | 1963 |
| Mr. Kevin Merrick Shook CPA | Pres of Workers Compensation Insurance - Eastern Alliance Insurance Group | 1969 |
| Mr. Lawrence K. Cochran | Chief Investment Officer, Head of Treasury & VP | NA |
| Michael A. Stoeckert | CTO & VP | NA |
| Mr. Frank B. O'Neil IRC | Sr. VP of Corp. Communications & Investor Relations | 1953 |
| Ms. Kathryn Anne Neville Esq. | Chief Compliance Officer & VP | NA |
| Ms. Noreen L. Dishart CCP, SPHR | Chief HR Officer & Exec. VP | 1964 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.